NCT06610669 The Prevalence of Hyper-Lp(a)-Emia in the PMMHRI-Lp(a) Registry
| NCT ID | NCT06610669 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Polish Mother Memorial Hospital Research Institute |
| Condition | Lipoprotein(a), Hyper-Lp(a)-Emia |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2022-01-01 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2022-01-01 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The PMMHRI-Lp(a)-Registry is a non-interventional, single-center registry conducted in the Polish Mother's Memorial Hospital Research Institute (PMMHRI). The PMMHRI-Lp(a)-Registry was established in January 2022. Since then, all consecutive patients of the Department of Cardiology and Adult Congenital Heart Diseases, Department of Endocrinology, and outpatient cardiology and endocrinology clinics with the measured Lp(a) concentration have been included.
Eligibility Criteria
Inclusion Criteria: * measured lipoprotein(a) concentration Exclusion Criteria: \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06610669 clinical trial?
This trial is open to participants of all sexes, studying Lipoprotein(a), Hyper-Lp(a)-Emia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06610669 currently recruiting?
Yes, NCT06610669 is actively recruiting participants. Contact the research team at maciej.banach@icloud.com for enrollment information.
Where is the NCT06610669 trial being conducted?
This trial is being conducted at Lodz, Poland.
Who is sponsoring the NCT06610669 clinical trial?
NCT06610669 is sponsored by Polish Mother Memorial Hospital Research Institute. The trial plans to enroll 2,000 participants.